BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17611688)

  • 1. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells.
    Ogawa M; Nakai S; Deguchi A; Nonomura T; Masaki T; Uchida N; Yoshiji H; Kuriyama S
    Int J Oncol; 2007 Aug; 31(2):323-31. PubMed ID: 17611688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.
    Hitomi M; Yokoyama F; Kita Y; Nonomura T; Masaki T; Yoshiji H; Inoue H; Kinekawa F; Kurokohchi K; Uchida N; Watanabe S; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):713-20. PubMed ID: 15703828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules.
    Kuriyama S; Hitomi M; Yoshiji H; Nonomura T; Tsujimoto T; Mitoro A; Akahane T; Ogawa M; Nakai S; Deguchi A; Masaki T; Uchida N
    Int J Oncol; 2005 Aug; 27(2):505-11. PubMed ID: 16010434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antitumor effects of vitamin K5 on hepatocellular carcinoma.
    Hitomi M; Nonomura T; Yokoyama F; Yoshiji H; Ogawa M; Nakai S; Deguchi A; Masaki T; Inoue H; Kimura Y; Kurokohchi K; Uchida N; Kuriyama S
    Int J Oncol; 2005 May; 26(5):1337-44. PubMed ID: 15809726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of vitamins K1, K2 and K3 effects on growth of rat glioma and human glioblastoma multiforme cells in vitro.
    Oztopçu P; Kabadere S; Mercangoz A; Uyar R
    Acta Neurol Belg; 2004 Sep; 104(3):106-10. PubMed ID: 15508263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Vitamin K3 and K5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells.
    Nakaoka E; Tanaka S; Onda K; Sugiyama K; Hirano T
    Anticancer Res; 2015 Nov; 35(11):6041-8. PubMed ID: 26504027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB; Zhou JH; Zuo MX; You QD
    Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activity of vitamins K1, K2 and K3 against human oral tumor cell lines.
    Okayasu H; Ishihara M; Satoh K; Sakagami H
    Anticancer Res; 2001; 21(4A):2387-92. PubMed ID: 11724297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K2-induced cell growth inhibition via autophagy formation in cholangiocellular carcinoma cell lines.
    Enomoto M; Tsuchida A; Miyazawa K; Yokoyama T; Kawakita H; Tokita H; Naito M; Itoh M; Ohyashiki K; Aoki T
    Int J Mol Med; 2007 Dec; 20(6):801-8. PubMed ID: 17982686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effects of vitamins K1, K2, and K3 against human T lymphoblastoid leukemia cells through apoptosis induction and cell cycle arrest.
    Xu W; Wu H; Chen S; Wang X; Tanaka S; Sugiyama K; Yamada H; Hirano T
    Chem Biol Drug Des; 2020 Oct; 96(4):1134-1147. PubMed ID: 32305047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo.
    Shimohara S; Murakami T; Morikawa M; Matsuo J; Nagayama S; Shuto T; Suico MA; Okiyoneda T; Yamatsu I; Mizushima T; Shimasaki T; Kai H
    Int J Oncol; 2005 Dec; 27(6):1527-33. PubMed ID: 16273208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
    Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
    Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis-inducing activity of vitamin C and vitamin K.
    Sakagami H; Satoh K; Hakeda Y; Kumegawa M
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):129-43. PubMed ID: 10726979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anticancer effects of vitamin K.
    Lamson DW; Plaza SM
    Altern Med Rev; 2003 Aug; 8(3):303-18. PubMed ID: 12946240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proliferation inhibition of glioma cells by vitamin K2].
    Sun L; Yoshii Y; Miyagi K; Ishida A
    No Shinkei Geka; 1999 Feb; 27(2):119-25. PubMed ID: 10065443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
    Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
    Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K2-induced antitumor effects via cell-cycle arrest and apoptosis in gastric cancer cell lines.
    Tokita H; Tsuchida A; Miyazawa K; Ohyashiki K; Katayanagi S; Sudo H; Enomoto M; Takagi Y; Aoki T
    Int J Mol Med; 2006 Feb; 17(2):235-43. PubMed ID: 16391821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.